India's preventive health push has now touched nearly half a billion lives. Union Health Minister J. P. Nadda on Wednesday, 21 October 2026 shared sweeping figures that put the scale of the government's non-communicable disease screening programme into sharp relief — 44 crore people screened for hypertension and diabetes alone since 2017-18, with millions more checked for three forms of cancer.

Posting in Hindi, Nadda said: 'Since 2017-18 we launched screening for hypertension, diabetes and oral, breast and cervical cancer. So far, 44 crore people have been screened for hypertension and diabetes, of whom 7.6 crore and 5 crore respectively have been identified. In addition, 37.7 crore have been screened for oral cancer, 17.7 crore for breast cancer and 9.8 crore for cervical cancer. This initiative has helped ensure early detection of diseases and timely treatment.'

A Programme Built on Two Pillars: NPCDCS and Ayushman Bharat

The screening drive did not emerge overnight. The National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), operationalised from 2010-11, laid the first architecture for opportunistic NCD screening at the community level. Then, in Budget 2018-19, the Ayushman Bharat announcement gave it a structural spine — upgrading sub-centres and primary health centres into Health and Wellness Centres (HWCs) with a mandate to conduct population-based screening for all five conditions Nadda cited.

Together, the two programmes represent India's most sustained institutional bet on catching disease before it becomes catastrophic. The logic is straightforward: hypertension and diabetes are largely silent until they cause a heart attack or kidney failure; oral, breast and cervical cancers are highly survivable if found early, and far less so if not.

Why the Numbers on Identified Cases Matter Most

Raw screening totals are impressive. But the more consequential figures are the ones buried inside them. Of 44 crore people screened for the two metabolic conditions, 7.6 crore were flagged as hypertensive and 5 crore as diabetic — together, that is more than the population of several large countries walking around with a diagnosis they may not have had before. For a country where NCDs now account for over 60 percent of all deaths, identifying these individuals at a primary health centre rather than an emergency ward is the difference between managed illness and preventable mortality.

The cancer screening numbers tell a parallel story. 37.7 crore screened for oral cancer, 17.7 crore for breast cancer, 9.8 crore for cervical cancer — all three conditions where India carries a disproportionate global burden, and all three where early-stage intervention dramatically changes outcomes.

The Bridge From Screening to Treatment

Diagnosis without follow-through is data, not healthcare. The government's stated ambition is to link those screened positive directly into the Ayushman Bharat PM-JAY insurance cover for treatment — closing the loop between detection at a wellness centre and hospitalisation cover for the uninsured poor. The further scale-up of HWCs toward the target of 1.5 lakh centres across the country is the infrastructure bet on which that linkage depends.

Every positive case identified today is a potential catastrophe averted tomorrow. That is the arithmetic this government is asking the country to accept — and nine years of programme data are now its strongest argument.